|
NAF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.8168000437413E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.50449996905166E-09 |
| Normal-vs-Stage2 |
4.77119999997555E-06 |
| Normal-vs-Stage3 |
3.754600E-04 |
| Normal-vs-Stage4 |
9.998700E-03 |
| Stage1-vs-Stage2 |
9.309200E-01 |
| Stage1-vs-Stage3 |
5.071000E-01 |
| Stage1-vs-Stage4 |
8.469800E-01 |
| Stage2-vs-Stage3 |
6.407400E-01 |
| Stage2-vs-Stage4 |
7.949600E-01 |
| Stage3-vs-Stage4 |
5.675000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.62140001214573E-09 |
| Normal-vs-AfricanAmerican |
7.17189996279899E-09 |
| Normal-vs-Asian |
1.028150E-04 |
| Caucasian-vs-AfricanAmerican |
4.332800E-01 |
| Caucasian-vs-Asian |
4.197200E-01 |
| AfricanAmerican-vs-Asian |
5.359600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.01090025239614E-10 |
| Normal-vs-Female |
5.967700E-04 |
| Male-vs-Female |
1.478090E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.22650000000668E-06 |
| Normal-vs-Extreme_Weight |
4.59450000267481E-09 |
| Normal-vs-Obese |
2.4216999999771E-06 |
| Normal-vs-Extreme_Obese |
9.29449999964582E-07 |
| Normal_Weight-vs-Extreme_Weight |
8.182800E-01 |
| Normal_Weight-vs-Obese |
4.033600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.254800E-01 |
| Extreme_Weight-vs-Obese |
2.194800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.988800E-01 |
| Obese-vs-Extreme_Obese |
1.685050E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.438200E-04 |
| Normal-vs-Age(41-60Yrs) |
3.44179999944849E-07 |
| Normal-vs-Age(61-80Yrs) |
2.96540014765867E-10 |
| Normal-vs-Age(81-100Yrs) |
5.0170999998933E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.973600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.078800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.575170E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.475900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.370190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.006000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.33919997313825E-09 |
| Normal-VS-Type2 PRCC |
9.78600001033669E-09 |
| Normal-VS-KIRP CIMP |
1.264190E-02 |
| Normal-VS-Unclassified PRCC |
1.563470E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.911600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.136800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.343600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.285600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.070400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.650600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.71299674234638E-11 |
| Normal-vs-N1 |
5.625600E-02 |
| Normal-vs-N2 |
2.539400E-03 |
| N0-vs-N1 |
3.117700E-02 |
| N0-vs-N2 |
8.399800E-01 |
| N1-vs-N2 |
4.046200E-01 |
|
|
